Lastly, prostate-specific membrane antigen (PSMA), which is a transmembrane glycoprotein and highly expressed in prostate cancer, was found to be expressed in high-grade gliomas due to tumor neovascularization [44,45]. This evidence concerns the gene FOLH1 and neoplasm.